MedTrace Logo

Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma

NCT05641441 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 258

Last updated 2025-01-13

No results posted yet for this study

Summary

The investigators aim to study the impact of stereotactic radiosurgery, for the treatment of vestibular Schwannoma, on the cochlear, vestibular, gustatory, and facial nerve functions and compare it with a conservatively treated group. The predictive value of radiological tumor characteristics on hearing preservation and vestibular function will be also evaluated.

Additionally, the investigators will invite patients with vestibular Schwannoma to fill out questionnaires to assess their quality of life.

Conditions

  • Vestibular Schwannoma
  • Ototoxicity

Interventions

RADIATION

Stereotactic radiosurgery

Stereotactic radiosurgery

Sponsors & Collaborators

  • University Hospital, Geneva

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-24
Primary Completion
2030-11-15
Completion
2030-11-15

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05641441 on ClinicalTrials.gov